Invesco
XGN icon

Invesco’s Exagen XGN Stock Holding History

Invesco’s Portfolio XGN Stock Details XGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$98.3K Buy
+21,133
New +$79.6K ﹤0.01% 3735
2025
Q4 		– Sell
-675,192
Closed -$7.42M – 3882
2025
Q3 		$7.42M Buy
+675,192
New +$5.98M ﹤0.01% 2015

Other funds holding XGN

WC
Wexford Capital West Palm Beach, Florida $782M AUM 62.56% 1-Year Est. Return
NCNMGF
Nano-Cap New Millennium Growth Fund Staten Island, New York $130M AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
FCM
FourWorld Capital Management New York $110M AUM 44.07% 1-Year Est. Return
SAM
Silvercrest Asset Management New York $15.3B AUM 40.56% 1-Year Est. Return
KCM
Kennedy Capital Management St Louis, Missouri $5.65B AUM 61.31% 1-Year Est. Return
MBAM
Mink Brook Asset Management West Palm Beach, Florida $227M AUM 64.76% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return

Invesco's XGN Position: Q2 2026 in Review

Invesco opened a new position in Exagen (XGN) in Q2 2026: 21,133 shares worth $98.3K. The stake represents ﹤0.01% of the portfolio and ranks #3735 among its holdings. This is a return to the name: Invesco previously reported a position in XGN as recently as Q3 2025.

Invesco first reported a position in XGN in Q3 2025 and has held it in 2 quarters since. The position peaked at $7.42M in Q3 2025. 57 funds tracked by Wall St. Rank hold XGN as of Q2 2026.

  • Invesco held 21,133 shares of Exagen worth $98.3K as of Q2 2026.
  • Exagen was a new Invesco position in Q2 2026.
  • Exagen made up ﹤0.01% of Invesco's portfolio in Q2 2026, its #3735 holding.
  • Invesco first reported a position in Exagen in Q3 2025 and has held it in 2 quarters since.
  • Invesco's Exagen position peaked at $7.42M in Q3 2025.
  • 57 funds tracked by Wall St. Rank held Exagen as of Q2 2026.

Based on Invesco's 13F filing for Q2 2026, filed 14 Aug 2026.